rs587780882

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000719.7(CACNA1C):​c.375A>G​(p.Pro125Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000145 in 1,514,324 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000012 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.82

Publications

0 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 12-2120328-A-G is Benign according to our data. Variant chr12-2120328-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 136642.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.83 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0000394 (6/152200) while in subpopulation EAS AF = 0.000963 (5/5194). AF 95% confidence interval is 0.000379. There are 0 homozygotes in GnomAd4. There are 5 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 6 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 47 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 47 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 47 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 47 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.465A>G p.Pro155Pro synonymous_variant Exon 3 of 50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 48 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 47 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.465A>G p.Pro155Pro synonymous_variant Exon 3 of 48 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 49 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 47 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 48 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 48 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.465A>G p.Pro155Pro synonymous_variant Exon 3 of 47 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.465A>G p.Pro155Pro synonymous_variant Exon 3 of 47 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.465A>G p.Pro155Pro synonymous_variant Exon 3 of 47 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.465A>G p.Pro155Pro synonymous_variant Exon 3 of 47 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 48 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 48 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 48 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 47 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 47 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 47 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 47 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 47 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 46 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 46 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 46 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 47 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 47 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 47 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 47 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 47 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 47 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.375A>G p.Pro125Pro synonymous_variant Exon 3 of 46 ENSP00000507309.1 Q13936-19
CACNA1CENST00000682152.1 linkc.324A>G p.Pro108Pro synonymous_variant Exon 2 of 6 ENSP00000506759.1 A0A804HHT8
CACNA1CENST00000480911.6 linkn.375A>G non_coding_transcript_exon_variant Exon 3 of 27 5 ENSP00000437936.2 F5H638

Frequencies

GnomAD3 genomes
AF:
0.0000394
AC:
6
AN:
152200
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000963
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000601
AC:
15
AN:
249396
AF XY:
0.0000887
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000774
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.0000117
AC:
16
AN:
1362124
Hom.:
0
Cov.:
24
AF XY:
0.0000146
AC XY:
10
AN XY:
683734
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31454
American (AMR)
AF:
0.00
AC:
0
AN:
44618
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25550
East Asian (EAS)
AF:
0.000306
AC:
12
AN:
39218
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84244
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53374
Middle Eastern (MID)
AF:
0.000178
AC:
1
AN:
5624
European-Non Finnish (NFE)
AF:
0.00000196
AC:
2
AN:
1020914
Other (OTH)
AF:
0.0000175
AC:
1
AN:
57128
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000394
AC:
6
AN:
152200
Hom.:
0
Cov.:
33
AF XY:
0.0000672
AC XY:
5
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41450
American (AMR)
AF:
0.00
AC:
0
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000963
AC:
5
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68030
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000508
Hom.:
0
Bravo
AF:
0.0000491

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
May 13, 2019
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: CACNA1C c.375A>G alters a non-conserved nucleotide resulting in a synonymous change. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 6e-05 in 249396 control chromosomes, predominantly at a frequency of 0.00077 within the East Asian subpopulation in the gnomAD database. The observed variant frequency within East Asian control individuals in the gnomAD database is approximately 80 fold of the estimated maximal expected allele frequency for a pathogenic variant in CACNA1C causing Arrhythmia phenotype (1e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of East Asian origin. To our knowledge, no occurrence of c.375A>G in individuals affected with Arrhythmia and no experimental evidence demonstrating its impact on protein function have been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, and both laboratories classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as benign. -

Oct 24, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Long QT syndrome Benign:1
Aug 20, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
May 02, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
9.0
DANN
Benign
0.73
PhyloP100
1.8

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587780882; hg19: chr12-2229494; API